Latest News
On Friday, Mark Cuban blasted what he described as runaway Medicare Advantage costs as congressional advisers push for tighter limits,
Via Benzinga · March 14, 2026
That's a huge advantage, after all.
Via The Motley Fool · March 14, 2026
Artificial intelligence is still the best growth sector in the market.
Via The Motley Fool · March 14, 2026
Via Talk Markets · March 14, 2026
Via Talk Markets · March 14, 2026
Despite graduating with a modest 2.65 GPA, Steve Jobs went on to co-found Apple Inc., return after being ousted in 1985 and lead the launch of iconic products like the iPod, iPhone and iPad, helping build the company into a $3.76 trillion tech giant.
Via Benzinga · March 14, 2026
Here's why the growth stock's pullback on Friday may have been an overreaction.
Via The Motley Fool · March 14, 2026
Anthony Scaramucci says he expects a fast cooling of a war-driven standoff, arguing President Trump could simply announce success and give markets a reason to rebound.
Via Benzinga · March 14, 2026
There's a reason I keep returning to this account year after year.
Via The Motley Fool · March 14, 2026
Via Talk Markets · March 14, 2026
Via Talk Markets · March 14, 2026
ServiceNow and Salesforce could be two better SaaS buys.
Via The Motley Fool · March 14, 2026
A contrarian view of the housing market can lead to riches for investors with a time horizon of more than a year.
Via The Motley Fool · March 14, 2026
Via Benzinga · March 14, 2026
These three AI stocks could climb in 2026.
Via The Motley Fool · March 14, 2026
Arm already powers most smartphones, but a quiet shift toward edge AI could change its revenue model in ways investors may not yet fully appreciate.
Via The Motley Fool · March 14, 2026
South Korean Prime Minister Kim Min-seok said that his White House meeting with President Trump left him with the impression that Trump still favors restarting talks with Kim Jong-un.
Via Benzinga · March 14, 2026

Fastly, a leading edge cloud platform provider, reported a notable insider sale amid a year of triple-digit stock gains.
Via The Motley Fool · March 14, 2026

Micron's stock has delivered impressive returns over the past few months.
Via The Motley Fool · March 14, 2026
Via Talk Markets · March 14, 2026
Via Talk Markets · March 14, 2026
Via Benzinga · March 14, 2026
Some recent artificial intelligence darlings have been crushed this year.
Via The Motley Fool · March 14, 2026

These three pipeline stocks are all solid long-term buys.
Via The Motley Fool · March 14, 2026
Broadcom's custom AI chip business is booming.
Via The Motley Fool · March 14, 2026
The annual developer conference of NVIDIA Corporation (NASDAQ: NVDA), known as Nvidia GTC (GPU Technology Conference), is set to commence on Monday, March 16-19.
Via Benzinga · March 14, 2026
The green hydrogen company has racked up losses for years, but recent strategic moves could get the stock back on track.
Via The Motley Fool · March 14, 2026
XRP's challenges could overshadow its catalysts.
Via The Motley Fool · March 14, 2026
Bloom Energy is in the right place at the right time.
Via The Motley Fool · March 14, 2026
Both of these companies are betting on ambitious plans.
Via The Motley Fool · March 14, 2026

Is CoreWeave a buy or a stock to avoid?
Via The Motley Fool · March 14, 2026
Warner Bros. Discovery (WBD) has record 16 noms for Sinners, but Polymarket odds favor One Battle After Another for Best Picture & Jordan for Best Actor.
Via Benzinga · March 14, 2026
Few funds have truly broken ground on new ideas, but this one definitely did.
Via The Motley Fool · March 14, 2026
Both companies are notable holdings in Berkshire Hathaway's portfolio, but one offers a more compelling mix of growth and durability.
Via The Motley Fool · March 14, 2026
You might not be as far off as you might think.
Via The Motley Fool · March 14, 2026
Investing in both gives investors broad global exposure.
Via The Motley Fool · March 14, 2026
Via Benzinga · March 14, 2026
AI infrastructure stocks held strong in a down market week.
Via The Motley Fool · March 14, 2026
Biomea Fusion (NASDAQ: BMEA) shares rose Friday after the company reported positive Phase II data for icovamenib in type 2 diabetes, highlighting durable efficacy and a favorable safety profile.
Via Benzinga · March 14, 2026
The meme coin is struggling to keep up with the bigger cryptocurrencies.
Via The Motley Fool · March 14, 2026
Steady returns of 10% (or even less) can create life-changing wealth over the long term.
Via The Motley Fool · March 14, 2026
Via Talk Markets · March 14, 2026
These three companies are well-positioned to be critical enablers of the AI economy.
Via The Motley Fool · March 14, 2026